A closed Caldrion transaction. The property, the seller and our partners are not named. Figures are as underwritten at closing; yield on cost, IRR and multiple are targets, not realized results.
At a glance
| Units | 412, across two properties |
| Built | 1986 and 1992 |
| Price | $46.0M ($112K per unit) |
| Going-in cap rate | 4.6%, on a distressed trailing 12 months |
| Structure | Joint venture, 90/10, with a San Antonio operator |
The asset
Two garden communities of 228 and 184 units, 2.5 miles apart in the Medical Center submarket, 22 buildings in total, close to the South Texas Medical Center and major employers.
The situation
A syndicator bought both properties in 2021 at $155K per unit using a floating-rate bridge loan. The rate cap expired, renovations stalled at 35% of units, and occupancy slipped to 86%. With the $51.5M loan maturing, the lender agreed to a discounted payoff.
Why it fit
Essential housing next to a major employment hub, bought well below replacement cost. The situation needed a buyer that could close quickly and fund deferred capital spending in the same step.
Business plan
- Finish renovating the remaining 268 units at $9,500 per unit for about a $140 premium.
- Address deferred maintenance for $3.4M: roofs on nine buildings, cast-iron sewer line replacement and foundation repairs.
- Run both properties under one management team and one insurance program. Implement RUBS and cut bad debt from about 6% to 1.5% through tighter screening.
Capital structure
$54.4M total, including $7.0M of capital spending. A fixed-rate loan at 60% LTC ($32.6M) plus $21.8M of equity (Caldrion $19.6M, operating partner $2.2M).
Underwriting at closing
- 4.6% going-in cap rate
- 6.8% stabilized yield on cost
- 16.0% target net IRR
- 1.95x equity multiple
- Five-year hold
Key risk
Execution on older buildings. A third-party property condition assessment was completed before closing, and the capital budget carries a $650K contingency.
See all our transactions, what we pass on and our criteria.
This case study is provided for information only. It is not an offer of securities or investment advice, and past or targeted results do not indicate future results.